Since our public debut through the successful completion of our DeSPAC transaction, Alpha Modus has remained unwavering in its mission to drive long-term shareholder value through the strategic ...

Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes ...

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature ...

CVR Partners' first quarter 2025 earnings news release will be distributed via GlobeNewswire and posted at ...

Vivani Medical (VANI) and Okava Pharmaceuticals announced an expansion of their collaboration to include dogs in the development of OKV-119, a ...

Over half of all dogs in the United States today are overweight or obese, placing them at increased risk for chronic diseases ...